ANALISIS PEMERIKSAAN LABORATORIUM PADA KASUS LEPTOSPIROSIS DISERTAI ABSES HATI AMOEBA

  • Donaliazarti Donaliazarti Universitas Abdurrab

Abstract

Leptospirosis merupakan penyakit yang disebabkan mikroorganisme spirochaeta genus Leptospira sedangkan abses hepar amoeba merupakan komplikasi ekstraintestinal oleh Entamoeba Histolytica. Kedua penyakit terjadi pada seorang pria 45 tahun dengan sanitasi diri dan lingkungan yang kurang. Abses hepar amoeba ditemukan sebagai koinsiden yang diperkirakan telah ada sebelum pasien mengalami leptospirosis sehingga kedua penyakit tersebut menimbulkan manifestasi klinis yang tumpang tindih pada pasien, namun gejala akut yang dialami pasien pada saat datang ke rumah sakit lebih besar kemungkinan disebabkan oleh leptospirosisnya. Pasien mengeluh demam tinggi, kulit dan mata menguning, buang air kecil seperti teh pekat, pegal pada kedua kaki, mual, muntah dan nyeri ulu hati. Pada pemeriksaan fisik ditemukan febris, takikardia, iketrik pada kulit dan sklera, injeksi siliar, dan hepatomegali. Pemeriksaan laboratorium menunjukkan anemia ringan dengan gambaran normositik normokrom, leukositosis dengan neutrofilia shift to the right, trombositosis, LED meningkat, APTT memanjang, hiperbilirubinemia, peningkatan enzim SGOT SGPT, ALP, serta GGT, hipoalbuminemia, hiperglobulinemia, dan bilirubinuria. Pemeriksaan mikroskopis dengan pewarnaan negatif pada sampel urine ditemukan Leptospira. Pemeriksaan USG abdomen menunjukkan space occupying lesion (SOL) soliter pada lobus kanan hati dan pada pemeriksaan serologi diperoleh antiamoeba positif. Berdasarkan hal diatas, maka pasien ini didagnosis mengalami leptospirosis koinsiden dengan abses hati amoeba.

Keywords: abses hati amoeba, leptospirosis, pemeriksaan laboratorium

References

[1] M. T. Brooks GF, Carrol KC, Butel JS, Morse SA, “Jawetz, Melnick, & Adelberg’s Medical Microbiology, 25th 2010,USA: McGraw Hill, 2010.
[2] K. V. Evangelista and J. Coburn, “Leptospira as An Emerging Pathogen: A Review of Its Biology, Pathogenesis and Host Immune Responses,” Future Microbiol., vol. 5, no. 9, pp. 1413–1425, 2010.
[3] Zein U, “Leptospirosis,” pada Buku Ajar Ilmu Penyakit Dalam, Jakarta: Penerbit FKUI, 2009
[4] L. J. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Harrison’s Principles of Internal Medicine, 18th Edition, USA: McGraw Hill, 2012.
[5] Ryan KJ & Ray CG, “Sherris Medical Microbiology, USA: McGraw Hill, 2004.
[6] Levett DN, “Leptospira,” in Principles and Practice of Clinical Bacteriology Editors, England : John Wiley & Sons, 2006.
[7] A. J. Shetty N, Tang JW, Infectious Disease : Pathogenesis, Prevention and Case Studies, United Kingdom: Wiley Blackwel, 2009.
[8] Sharma MP & Ahuja V, “Amoebic liver abscess,” J. Indian Acad. Clin. Med., vol. 4, no. 2, pp. 107–111, 2003.
[9] M. G. Netea, B. J. Kullberg, and J. W. M. Van der Meer, “Circulating cytokines as mediators of fever,” Clin. Infect. Dis., vol. 31, no. SUPPL. 5, pp. 178–184, 2000.
[10] R. W. Bauman, E. Machunis-Masuoka, and J. E. Montgomery, Microbiology: With Diseases by Body System, USA: Benjamin Cumming, 2012.
[11] Bonheur JL, “Biliary obstruction,” 2015. [Online]. Available: www.emedicine.medscape.com. [Accessed: 20-Dec-2015].
[12] Y. KS, B. AK, and R. K, “Serum Creatinine Phosphokinase [Cpk] an Early Marker in Human Leptospirosis,” Int. J. Med. Clin. Res., vol. 2, no. 2, pp. 29–33, 2011.
[13] A. Verma and B. Stevenson, “Leptospiral Uveitis - There Is More to It Than Meets the Eye!,” Zoonoses Public Health, vol. 59, no. SUPPL.2, pp. 132–141, 2012.
[14] M. B. Viana, “Anemia and infection: A complex relationship,” Rev. Bras. Hematol. Hemoter., vol. 33, no. 2, pp. 90–91, 2011.
[15] S. H. Lee, S. Kim, S. C. Park, and M. J. Kim, “Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells,” Infect. Immun., vol. 70, no. 1, pp. 315–322, 2002.
[16] Kresno SB, Imunologi : Diagnosis dan Prosedur Laboratorium, Edisi Kelima. Jakarta: Badan Penerbit FKUI, 2010.
[17] K. Nakada-Tsukui and T. Nozaki, “Immune response of amebiasis and immune evasion by Entamoeba histolytica,” Front. Immunol., vol. 7, no. MAY, pp. 1–13, 2016.
[18] J. L. Chen and K. Afsari, “Reactive thrombocytosis caused by infection,” Infections in Medicine, vol. 19, no. 10. pp. 480–483, 2002.
[19] J. F. P. Wagenaar et al., “Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality,” Trop. Med. Int. Heal., vol. 15, no. 2, pp. 152–159, 2010.
[20] Guyton AC & Hall JE, Textbook of Medical Physiology, Eleventh Edition. USA: Elsevier Saunders, 2006.
[21] M. Younes-Ibrahim et al., “Na,K-ATPase: A molecular target for Leptospira interrogans endotoxin,” Brazilian J. Med. Biol. Res., vol. 30, no. 2, pp. 213–223, 1997.
[22] N. S. Jain S, Gautam V, “Acute Phase Proteins: As Diagnostic Tool,” J Pharm Bioallied Sci, vol. 3, no. 1, pp. 118–127, 2011.
[23] Don BR & Kaysen G, “Serum Albumin: Relationship to Inflammation and Nutrition,” Semin. Dyalisis, vol. 17, no. 6, pp. 432–437, 2004.
[24] M. P. Hoffbrand AV, Pettit JE, Essential Haematology, Fourth Edition. USA: Blackwell Science, 2001.
[25] A. Cosme, E. Ojeda, I. Zamarreño, L. Bujanda, G. Garmendia, M. J. Echeverría et al., “Pyogenic versus amoebic liver abscesses. A comparative clinical study in a series of 58 patients,” Rev. Esp. Enfermedades Dig., vol. 102, no. 2, pp. 90–99, 2010.
[26] J. Cheriyan and M. J. Brown, “Primary prevention of CVD : treating hypertension Search date December 2007 Cardiovascular disorders Primary prevention of CVD : treating hypertension,” Cardiovasc. Disord., no. December 2009, pp. 1–20, 2010.
[27] I. Çetin, B. Yildirim, Ş. Şahin, I. Şahin, and I. Etikan, “Serum lipid and lipoprotein levels, dyslipidemia prevalence, and the factors that influence these parameters in a Turkish population living in the province of Tokat,” Turkish J. Med. Sci., vol. 40, no. 5, pp. 771–782, 2010.
Published
2021-02-07
Section
Articles
PDF
Abstract views: 316
downloads: 236